A Human Trigeminovascular Biomarker for Antimigraine Drugs: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial With Sumatriptan

Cephalalgia - United States
doi 10.1177/0333102416637833
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2016English

Donepezil for Dementia in Parkinson's Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2005English

Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial

Gut
Gastroenterology
2000English

CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial

The Lancet
Medicine
2017English

Dietary Fructo-Oligosaccharides in Healthy Adults Do Not Negatively Affect Faecal Cytotoxicity: A Randomised, Double-Blind, Placebo-Controlled Crossover Trial

British Journal of Nutrition
MedicineNutritionDietetics
2006English

Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial

The Lancet
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy